Nasus Pharma Ltd
- Stock Issuer and Owners
| Nasus Pharma Ltd |
| Ticker | NSRX |
| CIK # | 0002029039 |
| CUSIP | M7071P109 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 29 Harakevet St, Tel Aviv - Yafo, 6618003 |
| Source |
[EDGAR]
|
| Reg D Offering (Form D) |
Filed |
Raised |
Terms |
| Nasus Pharma Ltd |
2026-02-25 |
15.0 M |
Exemption: 506(b) · Duration: One year or less · Commission: $900,002 · Revenue: No Revenues
|
| 13F Ownership Over Time | Holders | Shares Held |
| 2026-03-31 |
9 |
2,174,274 |
| 2025-12-31 |
2 |
2,378 |
| 2025-09-30 |
2 |
3,241 |
| Form 13F Holdings |
| Firm |
Period |
DFND |
Voting |
Shares |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 217383606, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
325853371